Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Melatonin improved mental health and metabolism in women with PCOS.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Ozone therapy might improve cancer treatment and reduce its side effects.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Cavity macrophages gather on organ surfaces but don't really invade or help repair the organs after injury.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Higher fluoride levels may delay puberty in boys.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.